Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Truista Coffee Officially Launches With Doctor-Recommended, Lab-Verified "Clean Coffee" Standard Ready to Announce with Confidence?

newsfilecorp.com

Truista Coffee Officially Launches With Doctor-Recommended, Lab-Verified "Clean Coffee" Standard Ready to Announce with Confidence? Newport Beach, California--(Newsfile Corp. - February 18, 2026) - Truista Coffee, an organic coffee brand built on transparency and third-party verification, has officially launched nationwide. The company's first production release took place on September 29, 2025, National Coffee Day, marking both the public debut of the brand and the birthday of its founder.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

Click image above to view full announcement.

About Truista Coffee

Truista Coffee is an organic, non-toxic coffee company built on transparency and third-party verification. The company sources beans directly from trusted farms and uses proprietary processing methods designed to reduce contaminants while preserving flavor and antioxidants. Every bag features a QR code linking to batch-specific lab results. Truista Coffee is powered by a global collaboration of farmers, processors, and scientists, driving health-forward innovation and cup excellence from seed to sip.

Contacts:

Lindsay ONeill-O'Keefe

888-383-7862

lindsay@davincimedical.com

Source: Newsworthy.ai

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284318

Source: Reportable, Inc.

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Reportable, Inc. or all companies in the Multimedia / Internet / Online Services industry.

Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. (SRFM) Q425

2026-03-13 4:37 PM EDT

Stonegate Capital Partners Updates Coverage on Aquafil Group (ECNL) Q425

2026-03-13 1:12 PM EDT

Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease

2026-03-12 10:04 AM EDT

Jun 27, 2025

"Our company has issued news releases for over 25 years, often repeating our requirements with new providers. For the past six years,...

Multimedia / Internet / Online Services